+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

Biodefense Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023

Pre Book Price: $ 5216

Original Price: $ 5795

Biodefense is a measure to combat the potential effects of bioterrorism that utilizes biological agents, or deploys biological weaponry. Bioterrorism is a deliberate release of biological agents such as bacteria, virus, germs or toxins which may be in natural or human modified form, in order to make them more virulent, or to enhance their potential to cause infection, or to make them drug resistant. These biological agents can be transmittedthrough water, air, food or from person to person.Biodefense is usually utilized in two ways, either as a defense against an attack on a military target or civil population.  Defense against an attack on acivilian is largely based on the detection and methods by which casualties and loss of water or food can be minimized. Biodefense against an attack on military targets is concerned with preparing military personnelready to respond to bioterrorism.

Biological agents are classified into three categories on the basis of virulence as given below:
  • Category A,(high death rate, contagious and high impact on  people)
    • Anthrax,botulism,smallpox, tularemia,bubonic plague, ebola 
  • Category B(moderately easy to spread and low mortality rate)
    • Brucellosis,glanders, typhus, melioidosis
  • Category C(easily produced ,easily available,easily disseminateand high mortality rate)
    • Hantavirus, SARS, Nipah Virus, HIV/AIDS and H1N1 virus
Techniques used for commercial detection and identification of biological threat agents include:
  • Manual Biochemical Tests
  • Automated Biochemical Tests
  • Immunological Detection Devices
    • Solid-support platforms
      • BV technology
      • Bio-Detector
      • DELFIA
    • Lateral flow platforms
  • Nucleic Acid Detection via Quantitative PCR
    • Q-PCRthermocycler platforms
    • PCR reagent kits for biothreat agents
  • Bioluminescence Detection
Developing technologies for detection of biothreat agent include:
  • Biochemical Detection
  • Immunological Detection
    • Antibodies and fragments
    • Aptamers and peptide ligands
    • Flow cytometry
    • Biochip arrays
    • Surface plasmon resonance-based biosensors
    • Evanescent-wave biosensors
    • Cantilever and acoustic wave
    • Quantum dots and upconverting phosphors
  • Nucleic Acid Detection
  • Tissue and Cell-Based Detection
  • Chemical and Physical Detection
The global biodefense market is witnessing an admirable growth due to the disease surveillance mission which has become increasingly important with the fear of bioterrorism. After the attack of September 11, 2001 came the subsequent outbreak of anthrax, spores of which were mailed through the U.S. postal system. These events brought into notice that all levels of government need to focus on improving public health preparedness and to improve the response time for the next disaster. Bioterrorism preparedness funding has enabled the Public Health Services to significantly enhance the reach of its surveillance activities, thus more effectively monitor the community’s health. After the incidence, the focus was shifted to the development of tests and procedures to detect and identify bio threat agents. Recent outbreak in the form of Ebola and nuclear crisis in Japan are expected to significantly drive the growth of the biodefense market.

In terms of geography, North America followed by Europe accounted for the largest share of biodefense market due to enhanced lab capabilities, and improved activity for implementing rapid health alert system. Asia Pacific is expected to be a prospective biodefense market due to the rising adoption rate of precise analytical instruments and highly developing biotechnology industry. Moreover, other regions such as the Middle East and Latin America are expected to be the potential market in the near future due to expansion of major biotechnology players in these regions.

Some of the major players in biodefense market are Alnylam Pharmaceuticals, Acambis plc, Dynavax Technologies, Inc, Evogen, Inc., Emergent BioSolutions, Human Genome Sciences, SIGA Technologies, and PharmAthene, Inc. 

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of 
  • Market growth drivers 
  • Factors limiting market growth
  • Current market trends 
  • Market structure
  • Market projections for upcoming years 
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis. 

Reasons for Buying this Report
  • This report provides pin-point analysis for changing competitive dynamics
  • It provides a forward looking perspective on different factors driving or restraining market growth 
  • It provides a six-year forecast assessed on the basis of how the market is predicted to grow 
  • It helps in understanding the key product segments and their future
  • It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
  • It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments 
  • It provides distinctive graphics and exemplified SWOT analysis of major market segmentslude:
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.

To receive discount, please click on the button below.

Please click on the button below to customize this report.

Back To Top